STOCK TITAN

Mobix Labs (MOBX) Financials

MOBX NASDAQ
FY2025 annual
Revenue $9.9M +53.9% YoY
Net Income -$46.1M n/m YoY
EPS (Diluted) -$10.15 YoY not available
Free Cash Flow -$10.1M n/m YoY
Market Cap $5.8M as of Nov 20, 2026
Price / Sales 1.0x on $5.5M revenue, trailing 12 months to June 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026
Price / Book 0.9x on $6.2M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Currency USD FYE September

Newest figures come from the S-1 for Q3 FY2026, filed Oct 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MOBX SEC filings page.

Mobix Labs, Inc. (MOBX) reported $9.9M in revenue for fiscal year 2025, up 53.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MOBX FY2025

FY2025 growth improved gross margins, but overhead and financing needs still overwhelmed the company’s small operating base.

The business converted a narrower cash shortfall into a much larger reported loss: FY2025 net loss was $46.1M while operating cash flow was -$10.1M, compared with a FY2024 net loss of $20.0M and operating cash flow of -$18.4M. That gap indicates earnings were affected by substantial non-cash or non-operating items, yet the core business still did not generate cash.

Gross economics improved faster than the business’s cost structure. Revenue grew 53.9% in FY2025 and gross margin rose 10.9 percentage points to 50.5%, but gross profit of $5.0M remained far below selling, general and administrative expense of $39.6M. The resulting operating loss of $37.7M shows that better product-level profitability has not yet absorbed the corporate cost base.

The balance sheet is being supported by financing rather than operations. FY2025 liabilities of $37.4M slightly exceeded assets of $37.1M, leaving negative equity of -$336K and a current ratio of 0.2x. Financing cash flow of $13.1M alongside operating cash flow of -$10.1M shows external funding offsetting the operating cash deficit; reported liquidity equaled 3.9 months of the latest annual operating outflow.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 36 / 100
Financial Health Score 36/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Mobix Labs, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
16

Mobix Labs, Inc. held $3.3M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $10.1M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Mobix Labs, Inc. scores 16/100 among other emerging companies.

Dilution
5

Dilution ranks emerging companies on the yearly rate at which their shares outstanding grew across the last three fiscal years (the last two where the earliest reports none), a slower rise ranking higher because each round of funding spreads the same business across more owners. Mobix Labs, Inc. scores 5/100 on it among other emerging companies.

R&D Intensity
26

Mobix Labs, Inc. spent $2.4M on research and development in fiscal year 2025, which was 5.1% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Mobix Labs, Inc. scores 26/100 among other emerging companies.

Revenue Progress
90

Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. Mobix Labs, Inc. scores 90/100 on it among other emerging companies.

Burn Trend
65

Burn Trend ranks emerging companies on how far their operating cash flow moved between the newest fiscal year and the one two years earlier, measured against the cash the earlier year used, and a move toward generating cash ranks higher. Mobix Labs, Inc. scores 65/100 on it among other emerging companies.

Balance Sheet
16

Mobix Labs, Inc.'s cash, cash equivalents and investments came to $3.3M at the end of fiscal year 2025, against $37.4M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Mobix Labs, Inc. scores 16/100 among other emerging companies.

Altman Z-Score Distress
-9.35

Mobix Labs, Inc. scores -9.35, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $150.6M against total assets of $37.1M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

Mobix Labs, Inc. passes 5 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Mobix Labs, Inc. reported a net loss of $46.1M while operations used $10.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Mobix Labs, Inc. reported an operating loss of $37.7M against $2.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$789K
YoY-66.4%
QoQ-18.7%

Mobix Labs, Inc. generated $789K in revenue in Q3 2026. This represents a decrease of 66.4% from the same quarter a year earlier. Against the prior quarter it is down 18.7%.

EBITDA
-$6.9M
YoYn/m
QoQn/m

Mobix Labs, Inc.'s EBITDA was -$6.9M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$16.8M
YoYn/m
QoQn/m

Mobix Labs, Inc. reported a net loss of $16.8M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$1.33
QoQn/m

Mobix Labs, Inc. earned -$1.33 per diluted share (EPS) in Q3 2026. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Cash & Debt
$2.1M
YoY+792.5%
QoQ-16.4%

Mobix Labs, Inc. held $2.1M in cash against $2.4M in long-term debt as of Q3 2026.

Shares Outstanding
17M
QoQ+26.3%

Mobix Labs, Inc. had 17M shares outstanding in Q3 2026. Against the prior quarter it is up 26.3%.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
12.9%
YoY-44.5pp
QoQ-6.0pp

Mobix Labs, Inc.'s gross margin was 12.9% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 44.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.0 percentage points.

Return on Equity
-268.8%
YoY+1677.5pp
QoQ-202.6pp

Mobix Labs, Inc.'s quarterly ROE was -268.8% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 1677.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 202.6 percentage points.

Operating Margin

Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$411K
YoY-15.4%
QoQ-4.0%

Mobix Labs, Inc. invested $411K in research and development in Q3 2026. This represents a decrease of 15.4% from the same quarter a year earlier. Against the prior quarter it is down 4.0%.

Share Buybacks

Not reported for Q3 2026.

Capital Expenditures

Not reported for Q3 2026.

MOBX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOBX quarterly income statement
MetricQ3'26S-1Q2'26S-1/AQ1'26S-1Q4'25S-1Q3'25S-1Q2'2510-QQ1'2510-QQ4'2410-K
Revenue$789K-66.4%$970K-61.4%$1.9M-40.8%$1.9M-36.3%$2.4M+14.2%$2.5M+119.3%$3.2M+1011.9%$3.0M+582.2%
Cost of Revenue$687K-31.4%$786K-47.3%$1.3M-12.7%$931K-27.4%$1.0M-24.6%$1.5M+56.6%$1.5M+350.5%$1.3M+196.8%
Gross Profit$102K-92.4%$184K-82.0%$581K-65.6%$951K-43.1%$1.3M+84.5%$1.0M+428.5%$1.7Mn/m$1.7M+167100.0%
R&D Expenses$411K-15.4%$428K-40.5%$442K-27.7%$603K-58.4%$486K-64.5%$719K-48.5%$611K-60.9%$1.5M-20.9%
SG&A Expenses$7.0M-14.2%$5.8M-28.1%$9.0M-42.9%$7.5M-25.6%$8.2M-5.8%$8.1M+10.5%$15.7M+0.3%$10.1M+33580.0%
Operating Income-$7.4Mn/m-$6.1Mn/m-$8.8Mn/m-$7.2Mn/m-$8.1Mn/m-$7.8Mn/m-$14.6Mn/m-$11.2Mn/m
EBITDA-$6.9Mn/m-$5.7Mn/m-$8.4Mn/m-$6.7Mn/m-$7.6Mn/m-$7.3Mn/m-$14.0Mn/m-$10.7M-13020.0%
Interest Expense$868K+58.7%$1.4M+406.9%$1.4M+554.0%$1.3M+269.4%$547K+330.7%$274K+10.5%$211K-75.4%$350K-83.9%
Income Tax$3Kn/m$3Kn/m-$24Kn/m$16K-95.7%-$2Kn/m-$5Kn/m-$2Kn/m$372K+659.2%
Net Income-$16.8Mn/m-$5.9Mn/m-$10.1Mn/m-$15.7Mn/m-$8.3Mn/m-$2.3Mn/m-$19.8M-2221.8%-$11.5Mn/m
EPS (Basic)-$1.33-$0.59-$1.61-$2.99-$1.70-$0.57-$5.16-$3.80
EPS (Diluted)-$1.33-$0.59-$1.61-$2.99-$1.70-$0.57-$5.16-$3.90
Diluted Shares (Avg)13M10M6MN/A5M4M4MN/A

MOBX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOBX quarterly balance sheet
MetricQ3'26S-1Q2'26S-1/AQ1'26S-1Q4'25S-1Q3'25FilingQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$34.9M+1.1%$34.9M-4.6%$32.7M-12.2%$37.1M-5.1%$34.6M-16.3%$36.5M+23.9%$37.3M-10.1%$39.1M+108.5%
Current Assets$6.0M+64.0%$5.5M+38.2%$2.9M-24.9%$6.7M+27.4%$3.7M-9.7%$4.0M-10.7%$3.8M-75.9%$5.3M+535.1%
Cash & Equivalents$2.1M+792.5%$2.6M+228.2%$268K-33.8%$3.3M+1130.5%$240K+17.1%$781K-73.9%$405K-97.3%$266K+198.9%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Inventory$1.5M+17.3%$1.3M+16.7%$1.2M-5.9%$1.4M-16.8%$1.2M-34.6%$1.1M+206.4%$1.2M+194.3%$1.7M+440.8%
Accounts Receivable$760K-48.7%$724K-56.9%$1.0M-45.7%$1.4M-49.7%$1.5M+0.3%$1.7M+264.2%$1.9M+521.2%$2.8M+5207.5%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Goodwill$16.1M0.0%$16.1M0.0%$16.1M0.0%$16.1M0.0%$16.1M+5.7%$16.1M+49.3%$16.1M+49.3%$16.1M+208.0%
Total Liabilities$26.7M-21.7%$26.0M-28.1%$28.1M-30.4%$37.4M+11.6%$34.1M+4.2%$36.2M+42.8%$40.3M+8.7%$33.6M+54.0%
Current Liabilities$22.1M-17.0%$24.0M-23.7%$25.2M-11.2%$27.8M+6.4%$26.7M+4.7%$31.5M+74.7%$28.4M+32.6%$26.1M+27.8%
Non-Current Liabilities$4.6M-38.6%$2.0M-57.9%$2.8M-76.3%$9.7M+29.7%$7.4M+2.7%$4.7M-35.7%$11.9M-24.1%$7.5M+445.5%
Long-Term Debt$2.4M+73.1%$1.0M+83.0%$1.9M+119.8%$1.1M-14.3%$1.4M-57.1%$552K-82.5%$873K-82.4%$1.3M-80.5%
Total Equity$6.2M+1370.1%$8.8M+2486.3%$4.7Mn/m-$336K-106.1%$425K-95.0%$342K-91.8%-$3.0M-169.6%$5.5Mn/m
Retained Earnings-$183.4Mn/m-$166.6Mn/m-$160.7Mn/m-$150.6Mn/m-$134.9Mn/m-$126.6Mn/m-$124.3Mn/m-$104.5Mn/m

MOBX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOBX quarterly cash flow statement
MetricQ3'26S-1Q2'26S-1/AQ1'26S-1Q4'25S-1Q3'25S-1Q2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow-$5.7Mn/m-$4.3Mn/m-$4.8Mn/m-$4.5Mn/m-$4.1Mn/m-$586Kn/m-$930Kn/m-$3.6Mn/m
Depreciation & Amortization$437K-6.4%$424K-20.0%$455K-23.4%$467K-13.7%$467K-23.2%$530K+2.7%$594K+69.7%$541K+68.0%
Stock-Based Compensation$2.4M-66.9%$2.5M-26.8%$5.1M-47.6%N/A$7.1M+96.1%$3.4M+132.6%$9.8M-22.8%N/A
Capital ExpendituresN/AN/AN/A$10K$0N/AN/AN/A
Free Cash FlowN/AN/AN/A-$4.5M-$4.1MN/AN/AN/A
Investing Cash FlowN/AN/AN/A-$10Kn/m$27K-35.7%N/AN/A$0n/m
Financing Cash Flow$5.3M+50.5%$6.5M+569.4%$1.8M+64.6%$7.6M+105.2%$3.5M+1317.7%$978Kn/m$1.1M-94.2%$3.7M+136.5%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

MOBX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOBX quarterly financial ratios
MetricQ3'26S-1Q2'26S-1/AQ1'26S-1Q4'25S-1Q3'25S-1Q2'2510-QQ1'2510-QQ4'2410-K
Gross Margin12.9%-44.5pp19.0%-21.6pp31.0%-22.2pp50.5%-6.1pp57.4%+21.9pp40.6%+23.8pp53.2%+68.7pp56.6%+56.4pp
Operating Margin-932.1%-627.9%-471.1%-380.7%-343.4%-311.7%-461.7%-379.7%
Net Margin-2128.6%-603.4%-540.0%-835.8%-352.0%-91.2%-626.0%-390.6%
Return on Equity-268.8%+1677.5pp-66.2%+603.7pp-217.0%N/A-1946.4%-1856.4pp-669.9%-627.7ppN/A-208.6%
Return on Assets-48.1%-24.1pp-16.8%-10.5pp-30.9%+22.3pp-42.4%-12.9pp-23.9%-5.3pp-6.3%-0.3pp-53.2%-55.5pp-29.5%-29.5pp
Current Ratio0.27+0.1x0.23+0.1x0.110.0x0.240.0x0.140.0x0.13-0.1x0.13-0.6x0.20+0.2x
Debt-to-Equity0.38-2.9x0.11-1.5x0.41N/A3.25+2.9x1.61+0.9xN/A0.23
Liabilities-to-Equity4.28-76.0x2.94-102.9x6.01N/A80.31+76.5x105.82+99.7xN/A6.07
Asset Turnover0.020.0x0.030.0x0.060.0x0.050.0x0.070.0x0.070.0x0.09+0.1x0.08+0.1x
FCF MarginN/AN/AN/A-240.3%-173.8%N/AN/AN/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$336K), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.24), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Mobix Labs, Inc. MOBX FY2025 $9.9M -$46.1M N/A $5.8M 36/100
SemiLEDS Corporation LEDS FY2025 $43.0M -$1.1M -2.6% $15.5M 58/100
Peraso, Inc. PRSO FY2025 $12.2M -$4.8M -39.0% $5.3M 48/100
Sequans Communications S.A. SQNS FY2025 $26.3M -$109.3M N/A $31.1M 26/100
Pixelworks Inc PXLW FY2025 $693K -$22.5M N/A $40.0M —
Nano Labs Ltd NA FY2025 $3.8M $19.3M N/A $17.7M 22/100

Frequently Asked Questions

Mobix Labs, Inc. (MOBX) reported $9.9M in total revenue for fiscal year 2025. This represents a 53.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Mobix Labs, Inc. (MOBX) revenue grew by 53.9% year-over-year, from $6.4M to $9.9M in fiscal year 2025.

No, Mobix Labs, Inc. (MOBX) reported a net loss of $46.1M in fiscal year 2025.

Mobix Labs, Inc. (MOBX) reported diluted earnings per share of -$10.15 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Mobix Labs, Inc. (MOBX) had EBITDA of -$35.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Mobix Labs, Inc. (MOBX) had $3.3M in cash and equivalents against $1.1M in long-term debt.

Mobix Labs, Inc. (MOBX) had a gross margin of 50.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Mobix Labs, Inc. (MOBX) recorded an outflow of $10.1M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Mobix Labs, Inc. (MOBX) recorded an outflow of $10.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Mobix Labs, Inc. (MOBX) had $37.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Mobix Labs, Inc. (MOBX) invested $26K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Mobix Labs, Inc. (MOBX) invested $2.4M in research and development during fiscal year 2025.

Mobix Labs, Inc. (MOBX) had 7M shares outstanding as of fiscal year 2025.

Mobix Labs, Inc. (MOBX) had a current ratio of 0.24 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Mobix Labs, Inc. (MOBX) had a return on assets of -124.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Mobix Labs, Inc. (MOBX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $5.8M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Mobix Labs, Inc. (MOBX) trades at 1.0x sales, its market capitalization divided by $5.5M revenue, trailing 12 months to June 30, 2026. The market capitalization is $5.8M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Mobix Labs, Inc. (MOBX) held $3.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $10.1M over that year. Dividing the one by the other, the reported balance equals about 4 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Mobix Labs, Inc. (MOBX) has negative shareholder equity of -$336K as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Mobix Labs, Inc. (MOBX) has an Altman Z-Score of -9.35, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Mobix Labs, Inc. (MOBX) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Mobix Labs, Inc. (MOBX) reported a net loss of $46.1M while operations used $10.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Mobix Labs, Inc. (MOBX) reported an operating loss of $37.7M against $2.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Mobix Labs, Inc. (MOBX) scores 36 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top